Get Premium to unlock powerful stock data

Perceptive Advisors Llc Buys PROCEPT BioRobotics Corp, Icosavax Inc, IVERIC bio Inc, Sells Nevro Corp, United Therapeutics Corp, Kadmon Holdings Inc

Author's Avatar
insider
Nov 17, 2021
Article's Main Image
New York, NY, based Investment company Perceptive Advisors Llc (Current Portfolio) buys PROCEPT BioRobotics Corp, Icosavax Inc, IVERIC bio Inc, SomaLogic Inc, Sema4 Holdings Corp, sells Nevro Corp, United Therapeutics Corp, Kadmon Holdings Inc, Medtronic PLC, Neurocrine Biosciences Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Perceptive Advisors Llc. As of 2021Q3, Perceptive Advisors Llc owns 135 stocks with a total value of $6.1 billion. These are the details of the buys and sells.

For the details of PERCEPTIVE ADVISORS LLC's stock buys and sells, go to https://www.gurufocus.com/guru/perceptive+advisors+llc/current-portfolio/portfolio

These are the top 5 holdings of PERCEPTIVE ADVISORS LLC
  1. Mirati Therapeutics Inc (MRTX) - 3,387,745 shares, 9.88% of the total portfolio. Shares added by 6.34%
  2. BridgeBio Pharma Inc (BBIO) - 7,756,928 shares, 6.00% of the total portfolio.
  3. SpringWorks Therapeutics Inc (SWTX) - 4,849,912 shares, 5.07% of the total portfolio.
  4. Iovance Biotherapeutics Inc (IOVA) - 11,489,772 shares, 4.67% of the total portfolio. Shares added by 4.84%
  5. Amicus Therapeutics Inc (FOLD) - 26,559,443 shares, 4.18% of the total portfolio. Shares added by 14.87%
New Purchase: PROCEPT BioRobotics Corp (PRCT)

Perceptive Advisors Llc initiated holding in PROCEPT BioRobotics Corp. The purchase prices were between $35.91 and $41.94, with an estimated average price of $38.38. The stock is now traded at around $43.510000. The impact to a portfolio due to this purchase was 1.04%. The holding were 1,656,990 shares as of 2021-09-30.

New Purchase: Icosavax Inc (ICVX)

Perceptive Advisors Llc initiated holding in Icosavax Inc. The purchase prices were between $24.85 and $40.25, with an estimated average price of $34.02. The stock is now traded at around $26.790000. The impact to a portfolio due to this purchase was 0.94%. The holding were 1,922,549 shares as of 2021-09-30.

New Purchase: SomaLogic Inc (SLGC)

Perceptive Advisors Llc initiated holding in SomaLogic Inc. The purchase prices were between $10.2 and $12.77, with an estimated average price of $11.41. The stock is now traded at around $13.720000. The impact to a portfolio due to this purchase was 0.42%. The holding were 2,050,000 shares as of 2021-09-30.

New Purchase: Cue Health Inc (HLTH)

Perceptive Advisors Llc initiated holding in Cue Health Inc. The purchase prices were between $11.81 and $20, with an estimated average price of $15.75. The stock is now traded at around $13.140000. The impact to a portfolio due to this purchase was 0.31%. The holding were 1,580,607 shares as of 2021-09-30.

New Purchase: Sema4 Holdings Corp (SMFR)

Perceptive Advisors Llc initiated holding in Sema4 Holdings Corp. The purchase prices were between $0 and $12.25, with an estimated average price of $9.55. The stock is now traded at around $7.290000. The impact to a portfolio due to this purchase was 0.31%. The holding were 2,500,000 shares as of 2021-09-30.

New Purchase: Immuneering Corp (IMRX)

Perceptive Advisors Llc initiated holding in Immuneering Corp. The purchase prices were between $17 and $32.84, with an estimated average price of $26.9. The stock is now traded at around $27.650000. The impact to a portfolio due to this purchase was 0.3%. The holding were 681,051 shares as of 2021-09-30.

Added: IVERIC bio Inc (ISEE)

Perceptive Advisors Llc added to a holding in IVERIC bio Inc by 62.94%. The purchase prices were between $7.07 and $17.5, with an estimated average price of $10.82. The stock is now traded at around $16.480000. The impact to a portfolio due to this purchase was 0.77%. The holding were 7,471,798 shares as of 2021-09-30.

Added: Kodiak Sciences Inc (KOD)

Perceptive Advisors Llc added to a holding in Kodiak Sciences Inc by 61.25%. The purchase prices were between $81.97 and $106.94, with an estimated average price of $92.46. The stock is now traded at around $107.960000. The impact to a portfolio due to this purchase was 0.28%. The holding were 461,248 shares as of 2021-09-30.

Added: Viridian Therapeutics Inc (VRDN)

Perceptive Advisors Llc added to a holding in Viridian Therapeutics Inc by 79.11%. The purchase prices were between $10.69 and $18.2, with an estimated average price of $14.67. The stock is now traded at around $18.780000. The impact to a portfolio due to this purchase was 0.17%. The holding were 1,423,000 shares as of 2021-09-30.

Added: Inhibrx Inc (INBX)

Perceptive Advisors Llc added to a holding in Inhibrx Inc by 23.64%. The purchase prices were between $25.18 and $37.81, with an estimated average price of $30.45. The stock is now traded at around $43.940000. The impact to a portfolio due to this purchase was 0.12%. The holding were 1,121,490 shares as of 2021-09-30.

Added: Astria Therapeutics Inc (ATXS)

Perceptive Advisors Llc added to a holding in Astria Therapeutics Inc by 52.95%. The purchase prices were between $7.32 and $12.9, with an estimated average price of $9.62. The stock is now traded at around $6.920000. The impact to a portfolio due to this purchase was 0.1%. The holding were 1,959,652 shares as of 2021-09-30.

Added: Xenon Pharmaceuticals Inc (XENE)

Perceptive Advisors Llc added to a holding in Xenon Pharmaceuticals Inc by 20.43%. The purchase prices were between $14.86 and $19.45, with an estimated average price of $17.41. The stock is now traded at around $31.990000. The impact to a portfolio due to this purchase was 0.09%. The holding were 2,022,051 shares as of 2021-09-30.

Sold Out: Kadmon Holdings Inc (KDMN)

Perceptive Advisors Llc sold out a holding in Kadmon Holdings Inc. The sale prices were between $3.55 and $9.09, with an estimated average price of $5.66.

Sold Out: Medtronic PLC (MDT)

Perceptive Advisors Llc sold out a holding in Medtronic PLC. The sale prices were between $122.75 and $135.17, with an estimated average price of $129.47.

Sold Out: Dicerna Pharmaceuticals Inc (DRNA)

Perceptive Advisors Llc sold out a holding in Dicerna Pharmaceuticals Inc. The sale prices were between $19.68 and $39.99, with an estimated average price of $27.67.

Sold Out: Inari Medical Inc (NARI)

Perceptive Advisors Llc sold out a holding in Inari Medical Inc. The sale prices were between $71.29 and $95.99, with an estimated average price of $84.14.

Sold Out: Exact Sciences Corp (EXAS)

Perceptive Advisors Llc sold out a holding in Exact Sciences Corp. The sale prices were between $90.24 and $124.05, with an estimated average price of $105.88.

Sold Out: Acceleron Pharma Inc (XLRN)

Perceptive Advisors Llc sold out a holding in Acceleron Pharma Inc. The sale prices were between $115.25 and $182.78, with an estimated average price of $130.74.



Here is the complete portfolio of PERCEPTIVE ADVISORS LLC. Also check out:

1. PERCEPTIVE ADVISORS LLC's Undervalued Stocks
2. PERCEPTIVE ADVISORS LLC's Top Growth Companies, and
3. PERCEPTIVE ADVISORS LLC's High Yield stocks
4. Stocks that PERCEPTIVE ADVISORS LLC keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus